• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒毒素治疗的新适应症和新进展。

New and emerging indications of botulinum toxin therapy.

机构信息

Department of Neurology, Tokushima University Graduate School of Medicine, Kuramotocho 2-50-1, Tokushima, Japan.

出版信息

Parkinsonism Relat Disord. 2011 Nov;17 Suppl 1:S25-7. doi: 10.1016/j.parkreldis.2011.06.017.

DOI:10.1016/j.parkreldis.2011.06.017
PMID:21999892
Abstract

Botulinum neurotoxin (BoNT) is composed of the heavy chain with the receptor-binding site and the translocation domain and the light chain with endopeptidase activity that cleaves the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex, an essential molecule for membrane fusion. Its extraordinarily high toxicity depends on the affinity of the receptor-binding site to the receptor located inside the synaptosome. The membrane fusion mechanism is important not only in neurotransmitter release at the nerve terminals but also in the expression of pain receptors on the cell surface. Based on these mechanisms, BoNT is increasingly used for varieties of conditions including cosmetic uses, muscle hyperactivity, hyperhydrosis, pain, overactive bladder and epilepsy. It will become a major arm of neuromodulating treatments for neurological diseases. A part of this toxin, such as the heavy chain, may become a novel drug-delivery system for neurodegenerative diseases.

摘要

肉毒毒素(BoNT)由具有受体结合位点和易位结构域的重链和具有内切酶活性的轻链组成,该内切酶可切割 SNARE(可溶性 N-乙基马来酰亚胺敏感因子附着蛋白受体)复合物,该复合物是膜融合所必需的分子。其极高的毒性取决于受体结合位点与位于突触小体内的受体的亲和力。膜融合机制不仅在神经末梢的神经递质释放中很重要,而且在细胞表面的痛觉受体表达中也很重要。基于这些机制,BoNT 越来越多地用于各种疾病,包括美容用途、肌肉过度活跃、多汗症、疼痛、膀胱过度活动症和癫痫。它将成为神经调节治疗神经疾病的主要手段之一。这种毒素的一部分,如重链,可能成为神经退行性疾病的新型药物递送系统。

相似文献

1
New and emerging indications of botulinum toxin therapy.肉毒毒素治疗的新适应症和新进展。
Parkinsonism Relat Disord. 2011 Nov;17 Suppl 1:S25-7. doi: 10.1016/j.parkreldis.2011.06.017.
2
Gbetagamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition.Gβγ作用于SNAP-25的C末端以介导突触前抑制。
Nat Neurosci. 2005 May;8(5):597-605. doi: 10.1038/nn1439. Epub 2005 Apr 17.
3
[Mechanisms of action of botulinum toxins and neurotoxins].[肉毒杆菌毒素和神经毒素的作用机制]
Ann Dermatol Venereol. 2009 May;136 Suppl 4:S73-6. doi: 10.1016/S0151-9638(09)74531-4.
4
A botulinum neurotoxin-like function of Potentilla chinensis extract that inhibits neuronal SNARE complex formation, membrane fusion, neuroexocytosis, and muscle contraction.中药委陵菜提取物具有类似于肉毒杆菌神经毒素的功能,能够抑制神经元 SNARE 复合物的形成、膜融合、神经递质释放和肌肉收缩。
Pharm Biol. 2012 Sep;50(9):1157-67. doi: 10.3109/13880209.2012.661743.
5
Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.通过与无毒型肉毒神经毒素偶联的脂质体将 SNARE 裂解蛋白酶抑制剂靶向递送至运动神经末梢。
FEBS J. 2012 Jul;279(14):2555-67. doi: 10.1111/j.1742-4658.2012.08638.x. Epub 2012 Jun 14.
6
[Clostridium botulinum and botulinum neurotoxin].[肉毒梭菌与肉毒神经毒素]
Brain Nerve. 2011 Jul;63(7):755-61.
7
Activity-dependent changes in partial VAMP complexes during neurotransmitter release.神经递质释放过程中部分VAMP复合物的活性依赖性变化。
Nat Neurosci. 1999 Dec;2(12):1078-83. doi: 10.1038/16005.
8
Is the light chain subcellular localization an important factor in botulinum toxin duration of action?轻链的亚细胞定位是肉毒杆菌毒素作用持续时间的重要因素吗?
Mov Disord. 2004 Mar;19 Suppl 8:S23-34. doi: 10.1002/mds.20006.
9
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.肉毒杆菌神经毒素A选择性地切割突触蛋白SNAP - 25。
Nature. 1993 Sep 9;365(6442):160-3. doi: 10.1038/365160a0.
10
Engineered botulinum neurotoxins as new therapeutics.工程化肉毒神经毒素作为新型治疗药物。
Annu Rev Pharmacol Toxicol. 2014;54:27-51. doi: 10.1146/annurev-pharmtox-011613-135935. Epub 2013 Aug 30.

引用本文的文献

1
New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A.生成抗肉毒杆菌神经毒素A蛋白水解结构域特异性人单克隆抗体的新方法。
Bioimpacts. 2024;14(4):27680. doi: 10.34172/bi.2023.27680. Epub 2023 Dec 30.
2
Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.抗肉毒杆菌毒素的抗体与疫苗:现有措施及新方法
Toxins (Basel). 2019 Sep 12;11(9):528. doi: 10.3390/toxins11090528.
3
The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.
欧洲 AntibotABE 框架计划及其更新:创新性肉毒杆菌抗体的开发。
Toxins (Basel). 2017 Oct 2;9(10):309. doi: 10.3390/toxins9100309.
4
Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain.分离源自非人灵长类动物的纳摩尔级单链抗体片段,通过靶向肉毒杆菌神经毒素A1和A2的重链实现交叉中和。
BMC Biotechnol. 2015 Sep 17;15:86. doi: 10.1186/s12896-015-0206-0.
5
Enhancing the protective immune response against botulism.增强对肉毒中毒的保护性免疫应答。
Infect Immun. 2013 Jul;81(7):2638-44. doi: 10.1128/IAI.00382-13. Epub 2013 May 13.